Flagship Pioneering Special Opportunities Fund II, L.P.'s Net Worth

$0

Estimate Recalculated Sep 18, 2024 08:02PM EST

Who is Flagship Pioneering Special Opportunities Fund II, L.P.

Flagship Pioneering Special Opportunities Fund II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Foghorn Therapeutics Inc., and Sigilon Therapeutics, Inc..

SEC CIK

Flagship Pioneering Special Opportunities Fund II, L.P.'s CIK is 0001761283

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Omega Therapeutics, Inc.

Investor
Updated Feb 27, 2023
Form 4
60.26%
3.32M
$5.78
$19.21M
Feb 27, 2023
29.23M
Purchase
Feb 27
Form 4
-72.15%
-61.40M
$17.00
Aug 05, 2021
25.90M
Buy-Options
Aug 03
Form 3
Jul 29, 2021
2.20M
Showing 3 results

Foghorn Therapeutics Inc.

Investor
Updated May 24, 2024
Form 4
3.63M
$5.51
$20.00M
May 24, 2024
3.63M
Purchase
May 22
Form 4
-45.30%
-10.50M
$16.00
Oct 29, 2020
12.67M
Buy-Options
Oct 27
Form 3
Oct 22, 2020
Showing 3 results

Sigilon Therapeutics, Inc.

Investor
Updated Aug 15, 2023
Form 4
-100.00%
-797.72K
$14.92
-$11.90M
Aug 15, 2023
Disposition
Aug 11
Form 4
Dec 10, 2020
10.37M
Options
Dec 08
Form 3
Dec 03, 2020
Showing 3 results